Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn

UK’s GSK is leading the way in research but AstraZeneca is not involved in the area, report findsBusiness live – latest updatesThe pipeline of new drugs to fight superbugs remains “worryingly thin” and has shrunk by 35% in the last five years, experts have warned, predicting the...